$12.92
3.86% yesterday
Nasdaq, Nov 15, 10:02 pm CET
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Stock price

$12.92
-0.22 1.67% 1M
-2.19 14.49% 6M
-8.07 38.45% YTD
-4.71 26.72% 1Y
-8.63 40.05% 3Y
-4.75 26.88% 5Y
-7.14 35.59% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
+0.48 3.86%
ISIN
US8257041090
Symbol
SIBN
Sector

Key metrics

Market capitalization $541.84m
Enterprise Value $431.20m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.75
P/S ratio (TTM) P/S ratio 3.45
P/B ratio (TTM) P/B ratio 3.27
Revenue growth (TTM) Revenue growth 18.98%
Revenue (TTM) Revenue $157.04m
EBIT (operating result TTM) EBIT $-42.26m
Free Cash Flow (TTM) Free Cash Flow $-25.22m
Cash position $150.82m
EPS (TTM) EPS $-0.91
P/E forward negative
P/S forward 3.14
EV/Sales forward 2.47
Short interest 4.41%
Show more

Is SI-BONE, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

SI-BONE, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a SI-BONE, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a SI-BONE, Inc. forecast:

Buy
100%

Financial data from SI-BONE, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
157 157
19% 19%
100%
- Direct Costs 35 35
44% 44%
22%
122 122
13% 13%
78%
- Selling and Administrative Expenses 143 143
6% 6%
91%
- Research and Development Expense 17 17
17% 17%
11%
-38 -38
8% 8%
-24%
- Depreciation and Amortization 4.74 4.74
1% 1%
3%
EBIT (Operating Income) EBIT -42 -42
8% 8%
-27%
Net Profit -37 -37
14% 14%
-24%

In millions USD.

Don't miss a Thing! We will send you all news about SI-BONE, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SI-BONE, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
SI-BONE, Inc. (NASDAQ:SIBN ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Saqib Iqbal - Senior Director of Investor Relations Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants Craig Bijou - BofA Securities Young Li - Jefferies Drew Ranieri - Morgan Stanley Caitlin Cronin - Canaccord Richard Newi...
Neutral
GlobeNewsWire
3 days ago
SANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the quarter ended September 30, 2024.
Neutral
GlobeNewsWire
11 days ago
The iFuse Bedrock Granite™ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in conjunction with lumbar spinal fusion procedures The iFuse Bedrock Granite™ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in conjunction with lumbar spinal fusion procedures
More SI-BONE, Inc. News

Company Profile

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm's product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

Head office United States
CEO Laura Francis
Employees 344
Founded 2008
Website www.si-bone.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today